Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy

Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy

Albumin–bilirubin (ALBI) grade is an objective and reproducible model for evaluating overall survival (OS) in patients with hepatocellular carcinoma (HCC). However, the original ALBI grade was established for patients with Child–Pugh classes A–C. HCC patients with Child–Pugh class C or poor performa...

Full description

Bibliographic Details
Main Authors:	Wei-Fan Hsu, Shih-Chao Hsu, Te-Hong Chen, Chien-Hung Lin, Ying-Chun Lin, Yu-Wei Chang, Hung-Wei Wang, Yu-Min Liao, Hsueh-Chou Lai, Cheng-Yuan Peng
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Cancers
Subjects:	albumin–bilirubin (ALBI) grade curative therapy hepatocellular carcinoma modified ALBI grade survival
Online Access:	https://www.mdpi.com/2072-6694/14/20/5083

Similar Items

Predictive Power of the Albumin–Bilirubin Score for Hepatotoxicity in Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma
by: Jihyeon Joo, et al.
Published: (2023-07-01)

On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
by: Hung-Wei Wang, et al.
Published: (2021-07-01)

The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries
by: Chou SE, et al.
Published: (2023-02-01)

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
by: Jia-I Liao, et al.
Published: (2023-01-01)

Prediction Efficacy of Prognostic Nutritional Index and Albumin–Bilirubin Grade in Patients With Intrahepatic Cholangiocarcinoma After Radical Resection: A Multi-Institutional Analysis of 535 Patients
by: Qi Li, et al.
Published: (2021-12-01)

Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade
by: Shu-Yein Ho, et al.
Published: (2020-04-01)

Construction and validation of a novel prognostic model for intrahepatic cholangiocarcinoma based on a combined scoring system of systemic immune-inflammation index and albumin-bilirubin: a multicenter study
by: Haofeng Zhang, et al.
Published: (2023-09-01)

Clinical Role of Newly Developed ALBI and mALBI Grades for Treatment of Hepatocellular Carcinoma
by: Atsushi Hiraoka, et al.
Published: (2020-10-01)

Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Huilin Xu, et al.
Published: (2023-10-01)

Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis
by: Giovanni Marasco, et al.
Published: (2021-05-01)

Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency
by: Shu-Yein Ho, et al.
Published: (2023-11-01)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: Shu-Yein Ho, et al.
Published: (2023-03-01)

Performance of Albumin-Bilirubin (ALBI) score in comparison to other non-invasive markers in the staging of liver fibrosis in chronic HCV patients
by: Mohamed B. Hashem, et al.
Published: (2023-08-01)

Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
by: Tatsunori Miyata, et al.
Published: (2022-01-01)

Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma
by: Mao S, et al.
Published: (2021-11-01)

ALBI and PALBI Grades Are Associated with the Outcome of Patients with Stable Decompensated Cirrhosis
by: Theodora Oikonomou, et al.
Published: (2019-01-01)

Prediction of minimal encephalopathy in patients with HCV-related cirrhosis using albumin-bilirubin, platelets-albumin-bilirubin score, albumin-bilirubin-platelets grade and ammonia level
by: Ayman Alsebaey
Published: (2020-04-01)

Prediction of esophageal varices in patients with HCV-related cirrhosis using albumin-bilirubin, platelets-albumin-bilirubin score, albumin-bilirubin-platelets grade, and GAR
by: Ayman Alsebaey, et al.
Published: (2020-05-01)

Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients
by: Mai R, et al.
Published: (2019-10-01)

Assessment of the albumin-bilirubin score in breast cancer patients with liver metastasis after surgery
by: Li Chen, et al.
Published: (2023-11-01)

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
by: Kaoru Tsuchiya, et al.
Published: (2021-05-01)

Benefits of Local Treatment Including External Radiotherapy for Hepatocellular Carcinoma with Portal Invasion
by: Han Ah Lee, et al.
Published: (2021-04-01)

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
by: Kazuomi Ueshima, et al.
Published: (2019-07-01)

Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
by: Chen-Ta Chi, et al.
Published: (2021-08-01)

“Être d’un commerce agréable”
by: Cédric Calvignac, et al.
Published: (2014-06-01)

Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy
by: Chao An, et al.
Published: (2021-12-01)

Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker
by: Atsushi Hiraoka, et al.
Published: (2021-06-01)

A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma
by: Shu-Yein Ho, et al.
Published: (2022-01-01)

Prognostic Value of the Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Patients With Medulloblastoma Undergoing Surgical Resection
by: Sihan Zhu, et al.
Published: (2021-12-01)

Differential Response to Sorafenib Administration for Advanced Hepatocellular Carcinoma
by: Song-Fong Huang, et al.
Published: (2022-09-01)

Prognostic value of the albumin-bilirubin score in patients with non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis
by: Wanying Cheng, et al.
Published: (2023-05-01)

Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy
by: Masaki Kaibori, et al.
Published: (2022-10-01)

Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection
by: Yu-Chieh Tsai, et al.
Published: (2021-10-01)

ALBI score combined with FIB-4 index to predict post-hepatectomy liver failure in patients with hepatocellular carcinoma
by: Yi-Bo Tian, et al.
Published: (2024-04-01)

Predictive value of Albumin-Bilirubin grade for intravenous immunoglobulin resistance in a large cohort of patients with Kawasaki disease: a prospective study
by: Yu Yan, et al.
Published: (2021-09-01)

Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization
by: Hsin-Yeh Chen, et al.
Published: (2022-04-01)

The Predictive Value of ALBI and P-ALBI Scores in The Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B and Chronic Hepatitis B+D Induced Cirrhosis
by: Tolga ŞAHİN, et al.
Published: (2019-12-01)

ALBI and Child-Pugh score in predicting mortality in chronic liver disease patients secondary to alcohol - A retrospective comparative study
by: B S Nagaraja, et al.
Published: (2019-08-01)

High preoperative albumin-bilirubin score predicts poor survival in patients with newly diagnosed high-grade gliomas
by: Jie Zhang, et al.
Published: (2021-04-01)

FIB-4 and APRI for cirrhosis detection in a privately insured national cohort
by: Neehar D. Parikh, et al.
Published: (2024-01-01)